REPORTS

Let’s Pullulate and Expand Your Business

Gene Vector Market - Global Professional Analysis and Forecast to 2026

Nov 06, 2019  |  215 PAGES  |  REPORT CODE: CMM229887
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Gene Vector market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.6% during the forecast period.

This report presents the market size and development trends by detailing the Gene Vector market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Gene Vector market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Gene Vector industry and will help you to build a panoramic view of the industrial development.

Gene Vector Market, By Type:

  • Type 1

  • Type 2

  • Type 3

Gene Vector Market, By Application:

  • Medical care

  • Experiment

Some of the leading players are as follows:

  • Shimadzu Corporation (Japan)

  • SDIX, LLC (US)

  • Waters Corp. (US)

  • Thermo Fisher Scientific Inc. (US)

  • Takara Bio, Inc. (Japan)

  • BD Biosciences (US)

  • Promega Corporation (US)

  • Gallus Immunotech, Inc. (Canada)

  • A.G. Scientific, Inc. (US)

  • Meridian Life Science, Inc. (US)

  • R&D Systems (US)

  • Agilent Technologies, Inc. (US)

  • Qiagen N.V. (Netherlands)

  • PerkinElmer, Inc. (US)

  • Lonza Biologics Ltd. (Switzerland)

  • Abbott Diagnostics (US)

  • BioMerieux (France)

  • Merck KGaA (Germany)

  • Beckman Coulter, Inc. (US)

  • Bio-Rad Laboratories, Inc. (US)

  • GE Healthcare (UK)

  • Wako Pure Chemical Industries Ltd. (Japan)

  • F. Hoffmann-La Roche Ltd. (Switzerland)

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Gene Vector Market: Technology Type Analysis

  • 4.1 Gene Vector Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Gene Vector Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Type 1

    • 4.3.2 Type 2

    • 4.3.3 Type 3

5 Gene Vector Market: Product Analysis

  • 5.1 Gene Vector Product Market Share Analysis, 2018 & 2026

  • 5.2 Gene Vector Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Gene Vector Market: Application Analysis

  • 6.1 Gene Vector Application Market Share Analysis, 2018 & 2026

  • 6.2 Gene Vector Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Medical care

    • 6.3.2 Experiment

7 Gene Vector Market: Regional Analysis

  • 7.1 Gene Vector Regional Market Share Analysis, 2018 & 2026

  • 7.2 Gene Vector Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Shimadzu Corporation (Japan)

    • 9.1.1 Shimadzu Corporation (Japan) Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 SDIX, LLC (US)

    • 9.2.1 SDIX, LLC (US) Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Waters Corp. (US)

    • 9.3.1 Waters Corp. (US) Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Thermo Fisher Scientific Inc. (US)

    • 9.4.1 Thermo Fisher Scientific Inc. (US) Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Takara Bio, Inc. (Japan)

    • 9.5.1 Takara Bio, Inc. (Japan) Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 BD Biosciences (US)

    • 9.6.1 BD Biosciences (US) Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Promega Corporation (US)

    • 9.7.1 Promega Corporation (US) Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Gallus Immunotech, Inc. (Canada)

    • 9.8.1 Gallus Immunotech, Inc. (Canada) Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 A.G. Scientific, Inc. (US)

    • 9.9.1 A.G. Scientific, Inc. (US) Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Meridian Life Science, Inc. (US)

    • 9.10.1 Meridian Life Science, Inc. (US) Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 R&D Systems (US)

    • 9.11.1 R&D Systems (US) Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Agilent Technologies, Inc. (US)

    • 9.12.1 Agilent Technologies, Inc. (US) Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Qiagen N.V. (Netherlands)

    • 9.13.1 Qiagen N.V. (Netherlands) Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 PerkinElmer, Inc. (US)

    • 9.14.1 PerkinElmer, Inc. (US) Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Lonza Biologics Ltd. (Switzerland)

    • 9.15.1 Lonza Biologics Ltd. (Switzerland) Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Abbott Diagnostics (US)

    • 9.16.1 Abbott Diagnostics (US) Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 BioMerieux (France)

    • 9.17.1 BioMerieux (France) Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Merck KGaA (Germany)

    • 9.18.1 Merck KGaA (Germany) Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Beckman Coulter, Inc. (US)

    • 9.19.1 Beckman Coulter, Inc. (US) Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Bio-Rad Laboratories, Inc. (US)

    • 9.20.1 Bio-Rad Laboratories, Inc. (US) Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 GE Healthcare (UK)

    • 9.21.1 GE Healthcare (UK) Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

  • 9.22 Wako Pure Chemical Industries Ltd. (Japan)

    • 9.22.1 Wako Pure Chemical Industries Ltd. (Japan) Company overview

    • 9.22.2 Financial performance

    • 9.22.3 Product benchmarking

    • 9.22.4 Strategic initiatives

    • 9.22.5 SWOT analysis

  • 9.23 F. Hoffmann-La Roche Ltd. (Switzerland)

    • 9.23.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company overview

    • 9.23.2 Financial performance

    • 9.23.3 Product benchmarking

    • 9.23.4 Strategic initiatives

    • 9.23.5 SWOT analysis

 

The List of Tables and Figures (Totals 108 Figures and 120 Tables)

  • Figure Type 1 Gene Vector market, 2015 - 2026 (USD Million)

  • Figure Type 2 Gene Vector market, 2015 - 2026 (USD Million)

  • Figure Type 3 Gene Vector market, 2015 - 2026 (USD Million)

  • Figure Medical care market, 2015 - 2026 (USD Million)

  • Figure Experiment market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Gene Vector market, by country, 2015 - 2026 (USD Million)

  • Table North America Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table North America Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table North America Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Canada Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Canada Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Europe Gene Vector market, by country, 2015 - 2026 (USD Million)

  • Table Europe Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Europe Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Europe Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Germany Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Germany Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table France Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table France Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Italy Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Italy Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Spain Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Spain Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Gene Vector market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table China Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table China Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Japan Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Japan Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table India Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table India Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Gene Vector market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table MEA Gene Vector market, by country, 2015 - 2026 (USD Million)

  • Table MEA Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table MEA Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table MEA Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Gene Vector market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Gene Vector market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Gene Vector market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Shimadzu Corporation (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table SDIX, LLC (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Waters Corp. (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Thermo Fisher Scientific Inc. (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Takara Bio, Inc. (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BD Biosciences (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Promega Corporation (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Gallus Immunotech, Inc. (Canada) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table A.G. Scientific, Inc. (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Meridian Life Science, Inc. (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table R&D Systems (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Agilent Technologies, Inc. (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Qiagen N.V. (Netherlands) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table PerkinElmer, Inc. (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Lonza Biologics Ltd. (Switzerland) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Diagnostics (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BioMerieux (France) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck KGaA (Germany) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Beckman Coulter, Inc. (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bio-Rad Laboratories, Inc. (US) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GE Healthcare (UK) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Wako Pure Chemical Industries Ltd. (Japan) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table F. Hoffmann-La Roche Ltd. (Switzerland) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top